Common Contracts
2 similar And Security Agreement contracts by Accentia Biopharmaceuticals Inc
EX-10.61 64 dex1061.htm CONVERTIBLE SECURED PROMISSORY NOTE CONVERTIBLE SECURED PROMISSORY NOTE AND SECURITY AGREEMENT June 12, 2003 $ 875,538.47 New York, New YorkAnd Security Agreement • May 5th, 2020 • New York
FOR VALUE RECEIVED, Biovest International, Inc., a Delaware corporation with offices at 8500 Evergreen Blvd., Minneapolis MN 55433 and at 540 Sylvan Avenue, Englewood Cliffs, New Jersey 07632 (“Obligor”), hereby promises to pay to Morrison Cohen Singer & Weinstein, LLP, a New York limited liability partnership, 750 Lexington Avenue, New York, NY 10022 (“Payee”), the principal amount of Eight Hundred Seventy-Five Thousand Five Hundred Thirty-Eight and 47/100 Dollars ($875,538.47) (“Principal”), together with any accrued but unpaid interest thereon calculated in accordance with provisions of this Convertible Secured Promissory Note and Security Agreement (“Note”). Accentia, Inc. hereby acknowledges and agrees to the terms of this Note.
CONVERTIBLE SECURED PROMISSORY NOTE AND SECURITY AGREEMENTAnd Security Agreement • February 11th, 2005 • Accentia Biopharmaceuticals Inc • New York
FOR VALUE RECEIVED, Biovest International, Inc., a Delaware corporation with offices at 8500 Evergreen Blvd., Minneapolis MN 55433 and at 540 Sylvan Avenue, Englewood Cliffs, New Jersey 07632 (“Obligor”), hereby promises to pay to Morrison Cohen Singer & Weinstein, LLP, a New York limited liability partnership, 750 Lexington Avenue, New York, NY 10022 (“Payee”), the principal amount of Eight Hundred Seventy-Five Thousand Five Hundred Thirty-Eight and 47/100 Dollars ($875,538.47) (“Principal”), together with any accrued but unpaid interest thereon calculated in accordance with provisions of this Convertible Secured Promissory Note and Security Agreement (“Note”). Accentia, Inc. hereby acknowledges and agrees to the terms of this Note.
